23 results
424B3
CANF
Can-Fite Biopharma Ltd
1 Jun 20
Prospectus supplement
7:23am
in conducting such activities. In addition, the Company agreed to form a joint steering committee with Cipher which will oversee the progress
6-K
EX-99.1
1s0ad7tg8dx6k asez
1 Jun 20
Report of Foreign Private Issuer
7:06am
424B4
h1g2b050
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
msgk6s
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
leani4snovkhx69kxes
24 Jan 20
Registration statement (foreign)
4:40pm
F-1/A
EX-10.1
2hzj0 e3ofoxbtalq
17 Oct 19
Registration statement (foreign) (amended)
5:29pm
20-F/A
kqafyf5ro3fi7le5s
2 Apr 19
Annual report (foreign) (amended)
6:52am
424B3
w4n6xc90rxvxiq
22 Mar 19
Prospectus supplement
4:50pm
F-1/A
a5bct8mkskuvz6ye5dn
12 Mar 19
Registration statement (foreign) (amended)
4:20pm
F-1
5kx mied8ce
15 Feb 19
Registration statement (foreign)
4:32pm
6-K
EX-99.1
io7zjzse
8 Aug 18
Report of Foreign Private Issuer
5:03pm
6-K
EX-99.2
tv9 btd6f1za5dp9p
15 Sep 17
Report of Foreign Private Issuer
12:00am
424B3
54eog 35jvehupv
15 Sep 17
Prospectus supplement
12:00am